ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

2025

  • Home
  • 2025
February 19, 2025
Woman on smartphone
February 19, 2025
Categories
  • Special Topics

The Value of Patient-Reported Outcomes in Enhancing the Relevance of Clinical Trials

Patient-reported outcomes research has led to many discoveries that have influenced current research priorities and the way the Group designs its trials
Do you like it?
0 Read more
February 19, 2025
Research definition
February 19, 2025
Categories
  • Trial Results

Top Trial Results of 2024: A Year of Significant Advancements in Cancer Treatment

Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
Do you like it?
0 Read more
February 19, 2025
News in Brief
February 19, 2025
Categories
  • News in Brief

News in Brief, February 2025

Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more
June 25, 2025
June 25, 2025
Categories
  • Active Clinical Trials

Now Enrolling: EA4231 for Patients with Aggressive B-cell Lymphoma

This trial is evaluating a new drug combination for patients with cancer that has relapsed after remission or no longer responds to standard treatment
Do you like it?
0 Read more
Prev page
123

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc